http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201636020-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
filingDate | 2016-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_605084163314bbb6b078954c69d67c5c |
publicationDate | 2016-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201636020-A |
titleOfInvention | Cancer treatment |
abstract | An object of the present invention is to provide a method for treating a medicine/cancer comprising a compound having MDM2 inhibitory activity and a compound having FLT3 inhibitory activity.nThe solution of the present invention is to provide a combination (3'R, 4'S, 5'R)-N-[(3R,6S)-6-aminecarboxylidenetetrahydro-2H-pyran-3-yl]-6 "-Chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2"-sideoxy-1",2"-dihydrodispiro[cyclohexane -1,2'-pyrrolidin-3',3"-吲哚]-5'-carboxamide or a pharmaceutically acceptable salt thereof, and N-(5-tert-butyl-isoxazole-3 -yl)-N'-{4-[7-(2- oxalin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl Urea or a pharmaceutically acceptable salt thereof, or a combination therapy. |
priorityDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 335.